Search
for
Sort by
Research 541–570 of 1000+
- Evaluation of Sexual Dysfunctions in Male Patients with Androgenetic Alopecia
- Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- (163) Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
- SAT-148 Late Diagnosis of Klinefelter Syndrome: Overcoming Phenotypic Variability and Diagnostic Oversights
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Randomized controlled trial on the efficacy and safety of the combination therapy of topical 0.1% finasteride − 5% Minoxidil in male androgenetic alopecia
- Premarital Counseling in Relation to Common STDs, Andrological and Dermatological Disorders in Menoufia Governorate
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Risk associated with the use of 5-alpha reductase inhibitors with minoxidil in treatment of male androgenetic alopecia – literature review
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism
- 8679 Case: The Sexual, Physical and Psychological Effects of Post-Finasteride Syndrome
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Does Propecia Cause More Harms than Good: Assessing Reproductive and Non-Reproductive Effects of Finasteride on Male Health
- Role of Dutasteride in the Treatment of Androgenetic Alopecia
- (171) EFFECT OF FINASTERIDE TREATMENT AND ITS WITHDRAWAL IN THE RAT CORPUS CAVERNOSUM
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- Treatment of hyperestrogenism in men of fertile age with testicular testosterone deficit
- The Role of Topical Finasteride in Hair Loss Management: Current Evidence and Future Perspectives
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo evidence
- Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
- Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)
- Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database review.
- Serum testosterone levels and clinical signs of hypogonadism in men with type 2 diabetes
- Summary of Hair Diseases: Cicatricial and Non-Cicatricial
- Sac Beyazlama ve Sac Kaybı Skorları ile Erektil Disfonksiyon Arasındaki Iliski
- MP85-03 SEXUAL DYSFUNCTION IN MEN WITH PRE-DIABETES – RESULTS FROM A CROSS-SECTIONAL STUDY
- 175 Reinventing the Selfie: Telemedicine in a Tertiary Referral Sexual Medicine Practice